During mammary gland development, MeCP2 expression in mammary luminal‐restricted progenitor/mature luminal cells is higher than that in bi‐potent mammary stem cells, suggesting that MeCP2 maybe play an important role in maintaining luminal breast cancer and inhibiting proliferation of TNBC cell lines. Here, MECP2 is linked to breast carcinoma.